Distribution of human papillomavirus in a family planning population in Nairobi, Kenya

Sexually Transmitted Diseases

Volumn 30, Issue 2, 2003, Pages 137-142

  De Vuyst, Hugo ^a   Steyaert, Sophia ^b   Van Renterghem, Lieve ^b   Claeys, Patricia ^a   Muchiri, Lucy ^c   Sitati, Susan ^c   Vansteelandt, Stijn ^a   Quint, Wim ^d   Kleter, Bernard ^d   Van Marck, Eric ^e   Temmerman, Marleen ^a,f  

^a GHENT UNIVERSITY   (Belgium)

^b GHENT UNIVERSITY HOSPITAL   (Belgium)

^c UNIVERSITY OF NAIROBI   (Kenya)

^d R de Graaf Hospital   (Netherlands)

^e ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^f ICRH   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA; VIRUS VACCINE;

ADULT; ARTICLE; CANCER INVASION; CANCER RISK; CONTROLLED STUDY; FAMILY PLANNING; FEMALE; HUMAN; HUMAN TISSUE; KENYA; MAJOR CLINICAL STUDY; PAPANICOLAOU TEST; POPULATION RESEARCH; PREVALENCE; RISK ASSESSMENT; SEROLOGY; SEROPREVALENCE; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; VACCINATION; VIRUS STRAIN; WART VIRUS;

ADULT; CERVICAL INTRAEPITHELIAL NEOPLASIA; DNA, VIRAL; FAMILY PLANNING SERVICES; FEMALE; HUMANS; KENYA; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 0037316573     PISSN: 01485717     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007435-200302000-00009     Document Type: Article

References (37)

1. Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide incidence of 25 major cancers in 1990. Int J Cancer 1999; 80:827-841.
2. World Health Organization. Selected aspects of reproductive ill-health: 1990-1995. Available at: http://www.who.int/rht/rhtdimensions.htm. Accessed July 20, 2001.
3. Parkin DM, Stjensward J, Muir C. Estimates of world-wide frequency of twelve major cancers. Bull WHO 1984; 62:163.
4. Muñoz N, Herrero R, Lazcano E, et al. HPV prevalence surveys in general populations. Presented at the 4th International Multidisciplinary Congress, Eurogyn: Global Challenges of Cervical Cancer Prevention. Paris, 2000.
5. Parkin DM, Whelan SL, Ferlay J, Raymond L, Young J. Cancer Incidence in Five Continents. Vol. VII, no. 143. Lyon: IARC Scientific Publication, 1997.
6. Parkin DM, Wabinga H, Nambooze S, Wabwire-Mangen F. AIDS- related cancers in Africa: maturation of the epidemic in Uganda. AIDS 1999; 13:2563-2570.
7. Schiffman MH, Bauer HM, Hoover RN, et al. Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. J Natl Cancer Inst 1993; 85:958-964.
8. Walboomers JM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999; 189:12-19.
9. Ferrera A, Velema JP, Figueroa M, et al. Human papillomavirus infection, cervical dysplasia and invasive cervical cancer in Honduras: a case-control study. Int J Cancer 1999; 82:799-803.
10. Herrero R, Hildesheim A, Bratti C, et al. Population-based study of human papillomavirus infection and cervical neoplasia in rural Costa Rica. J Natl Cancer Inst 2000; 92:464-474.
11. Chaouki N, Bosch FX, Munoz N, et al. The viral origin of cervical cancer in Rabat, Morocco. Int J Cancer 1998; 75:546-554.
12. Chichareon S, Herrero R, Munoz N, et al. Risk factors for cervical cancer in Thailand: a case-control study. J Natl Cancer Inst 1998; 90:50-57.
13. Muñoz N, Bosch FX, Chichareon S, et al. A multinational case-control study on the risk of cervical cancer linked to 25 HPV types: which are the high-risk types? Presented at the 18th International Papillomavirus Conference. Barcelona, 2000.
14. zur Hausen H. Papillomavirus infections: a major cause of human cancers. Biochim Biophys Acta 1996; 1288:F55-F78.
15. van Ranst M, Kaplan JB, Burk RD. Phylogenetic classification of human papillomaviruses: correlation with clinical manifestations. J Gen Virol 1992; 73:2653-2660.
16. Lorincz AT, Reid R, Jenson AB, Greenberg MD, Lancaster W, Kurman RJ. Human papillomavirus infection of the cervix: relative risk associations of 15 common anogenital types. Obstet Gynecol 1992; 79:328-337.
17. Bosch FX, Manos MM, Munoz N, et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International Biological Study of Cervical Cancer (IBSCC) Study Group. J Natl Cancer Inst 1995; 87:796-802.
18. Herrero R, Matos E, Muñoz N, et al. Seroreactivity to HPV 16, 18, 31, 33 and 58 L1 VLPs in a population-based sample of women in Concordia, Argentina. Presented at the 18th International Papillomavirus Conference. Barcelona, 2000.
19. Ho GYF, Studentsov YY, Bierman R, Beardsley L, Burk RD. Anti-VLP16 responses in young women protect against subsequent HPV infections. Presented at the 18th International Papillomavirus Conference. Barcelona, 2000.
20. Bosch FX, Rohan T, Schneider A, et al. Papillomavirus research update: highlights of the Barcelona HPV 2000 international papillomavirus conference. J Clin Pathol 2001; 54:163-175.
21. Luff RD. The Bethesda System for reporting cervical/vaginal cytologic diagnoses: report of the 1991 Bethesda workshop. The Bethesda System Editorial Committee. Hum Pathol 1992; 23:719-721.
22. Kleter B, van Doorn LJ, ter Schegget J, et al. Novel short-fragment PCR assay for highly sensitive broad-spectrum detection of anogenital human papillomaviruses. Am J Pathol 1998; 153:1731-1739.
23. Kleter B, van Doorn LJ, Schrauwen L, et al. Development and clinical evaluation of a highly sensitive PCR-reverse hybridization line probe assay for detection and identification of anogenital human papillomavirus. J Clin Microbiol 1999; 37:2508-2517.
24. Erlich HA, Bugawan TL. HLA DNA typing. In: Innis MA, Gelfand DH, Sninsky JJ, White TJ, eds. PCR Protocols: A Guide to Methods and Applications. San Diego, CA: Academic Press, 1990:261-271.
25. Wertlake PT, Francus K, Newkirk GR, Parham GP. Effectiveness of the Papanicolaou smear and speculoscopy as compared with the Papanicolaou smear alone: a community-based clinical trial. Obstet Gynecol 1997; 90:421-427.
26. Greenland RA. Modern Epidemiology. 2nd ed. Philadelphia, PA: Lippincott-Raven, 1998.
27. Eluf-Neto J, Booth M, Munoz N, Bosch FX, Meijer CJ, Walboomers JM. Human papillomavirus and invasive cervical cancer in Brazil. Br J Cancer 1994; 69:114-119.
28. Munoz N, Bosch FX, de Sanjose S, et al. The causal link between human papillomavirus and invasive cervical cancer: a population-based case-control study in Colombia and Spain. Int J Cancer 1992; 52:743-749.
29. Ngelangel C, Munoz N, Bosch FX, et al. Causes of cervical cancer in the Philippines: a case-control study. J Natl Cancer Inst 1998; 90:43-49.
30. Rolon PA, Smith JS, Munoz N, et al. Human papillomavirus infection and invasive cervical cancer in Paraguay. Int J Cancer 2000; 85: 486-491.
31. van Ranst MA, Tachezy R, Delius H, Burk RD. Taxonomy of human papillomaviruses. Papillomavirus Rep 1993; 4:61-65.
32. Ponten J, Adami HO, Bergstrom R, et al. Strategies for global control of cervical cancer. Int J Cancer 1995; 60:1-26.
33. Johnson JC, Barnett AF, Willet GD, Young MA, Doniger J. High frequency of latent and clinical human papillomavirus cervical infections in immunocompromised human immunodeficiency virus-infected women. Obstet Gynecol 1992; 79:321-327.
34. Mandelblatt JS, Fahs M, Garibaldi K, Senie RT, Peterson HB. Association between HIV infection and cervical neoplasia: implications for clinical care of women at risk for both conditions. AIDS 1992; 6:173-178.
35. Temmerman M, Tyndall MW, Kidula N, Claeys P, Muchiri L, Quint W. Risk factors for human papillomavirus and cervical precancerous lesions, and the role of concurrent HIV-1 infection. Int J Gynaecol Obstet 1999; 65:171-81.
36. Kreiss JK, Kiviat NB, Plummer FA, et al. Human immunodeficiency virus, human papillomavirus, and cervical intraepithelial neoplasia in Nairobi prostitutes. Sex Transm Dis 1992; 19:54-59.
37. World Health Organization. The current status of development of prophylactic vaccines against human papillomavirus infection: report of a technical meeting, Geneva, 16-18 February 1999. Geneva: World Health Organization, 1999. Available at: http://www.who.int/ vaccines-documents/doxgen/H4-Inno.htm.